Stock Ticker

  • Loading stock data...

Mallinckrodt PLC (NYSE:MNK) Pays $5.8 billion To Acquire Questcor Pharmaceuticals Inc (NASDAQ:QCOR)

Boston, MA 08/19/2014 (wallstreetpr) –According to recent reports, Mallinckrodt PLC (NYSE:MNK) has decided to acquire Questcor Pharmaceuticals Inc (NASDAQ:QCOR). The deal has been valued at approximate $5.8 billion. The shares of MNK surged as soon as this news came out. MNK To Join S&P 500 Club: The shares of the company inclined by 1.1% after […]

In A $5.6 Billion Deal, Questcor Pharmaceuticals Inc (NASDAQ:QCOR) Get Past Major Hurdle

Boston, MA 05/21/2014 (wallstreetpr) – The drug maker Questcor Pharmaceuticals Inc (NASDAQ:QCOR) just got over a major hurdle in its efforts to merge into a fellow drug company. The U.S. Federal Trade Commission announced the termination of the antitrust review of the deal between Questcor and Mallinckrodt PLC (NYSE:MNK). The development gives the companies an […]

Start Due Diligence Here: Mallinckrodt PLC (NYSE:MNK), Targa Resources Partners LP (NYSE:NGLS), LyondellBasell Industries NV (NYSE:LYB)

Boston, MA 05/20/2014 (wallstreetpr) – The proposed tie-up of Mallinckrodt PLC (NYSE:MNK) and Questcor Pharmaceuticals Inc (NASDAQ:QCOR) just got over a major hurdle following the U.S. Antitrust approval of the deal, quicker than usual. That marks an important milestone for the two specialty pharmaceuticals that seek to join forces to take advantage of their respective strengths […]

Questcor Pharmaceuticals Inc (NASDAQ:QCOR)’s Acthar Continue To Dominate

Boston, MA 05/09/2014 (wallstreetpr) – Questcor Pharmaceuticals Inc (NASDAQ:QCOR)’s Acthar continues to focus on treatment of multiple indications. The recent studies proved that Acthar may be an alternate option for the treatment of systemic lupus erythematosus (SLE) patients. Acthar The U.S. Food and Drug Administration (FDA) already approved the medicines for 19 indications including the treatment […]

Questcor Pharmaceuticals Inc (NASDAQ:QCOR) Enters Into An Agreement With Mallinckrodt PLC (NYSE:MNK)

Boston, MA 04/10/2014 (wallstreetpr) – Questcor Pharmaceuticals Inc (NASDAQ:QCOR) along with Mallinckrodt PLC (NYSE:MNK) made an announcement on April 7, 2014 that the two firms have signed a definite merger agreement with each other. According to this agreement MNK will be acquiring QCOR through a transaction worth up to $5.6 billion. This transaction has already been […]

Investigation for Sales on Questcor Pharmaceuticals Inc (NASDAQ:QCOR)

Boston, MA 04/09/2014 (wallstreetpr) – The globally leading Pharmaceutical Company called Questcor Pharmaceuticals Inc (NASDAQ:QCOR) is now under the scanner of Faruqi and Faruqi. As a Questcor investor alert, Faruqi and Faruqi, LLP has announced investigation of QCOR (Questcor Pharmaceuticals, Inc.) over the sale of the company to Mallinckrodt plc. Faruqi and Faruqi, LLP, which is […]

Mallinckrodt Agrees to Acquire Questcor Pharmaceuticals Inc. (NASDAQ:QCOR) for $5.6 Billion

Boston, MA 04/07/2014 (wallstreetpr) – Ireland’s Mallinckrodt has announced it his inline to complete the acquisition of Questcor Pharmaceuticals Inc. (NASDAQ:QCOR), in a stock and cash deal valued at $5.2 billion. Questcor is a biopharmaceutical company specialized in the development of treatments for serious medical conditions. Mallinckrodt on its part develops a wide range of specialty […]

Sign Up To Get Our Latest Stocks Alerts